Performance of high-level Spanish athletes in the Olympic Games according to gender.

No studies have been found that analyzed the probabilities of high-level athletes according to gender for accessing programs that promote the professionalization of sports, and participation and success in the OG in Spain. This could explain the gender differences in these parameters and the trend towards more egalitarian data in recent years. The objective of this study was to analyze the probabilities of Spanish high-level athletes for participating and achieving sporting success in the 2008, 2012 and 2016 Olympic Games (OG). Data relating to a sample of 3757 high-level Spanish athletes (2398 men and 1359 women) between 2005 and 2016 were examined. The variables of gender, having obtained a scholarship from the Association of Olympic Athletes (ADO) program, training in a High Performance Center (CAR), participation and performance in the OG were analyzed. It was found that high-level female athletes were more likely than male athletes to belong to the ADO program (χ2 = 26,151; r* = 0.083; p = 0,000) and CAR (χ2 = 13,847; r* = 0.061; p = 0,000), and to qualify for an OG (χ2 = 22,838; r* = 0,078; p = 0,000), the same trend was found in the three Olympic cycles analyzed. With respect to the results in the OG, in general, no differences were found according to gender, although women were more likely to be finalists (χ2 = 4,406; r* = 0.071; p = 0,036), and more prominently in the 2016 OG (16.118; r* = 0.228; p = 0.000). The same applies to winning a medal (χ2 = 5.939; r* = 0.145; p = 0.015), more specifically bronze at the 2012 OG (χ2 = 6.215; r* = 0.149; p = 0.013). In conclusion, high-level female athletes in Spain have a higher percentage of access to high-level athlete support programs such as ADO and CAR, as well as participation in OG.

Quality of life monitoring in ambulatory heart failure patients: temporal changes and prognostic value.

AIMS: Heart failure (HF) is a chronic condition that typically affects a patient's quality of life (QoL). Little is known about long-term QoL monitoring in HF. This study aimed to evaluate the temporal changes and prognostic value of QoL assessment in a real-life cohort of HF patients. METHODS AND RESULTS: The Minnesota Living with Heart Failure Questionnaire was used to monitor QoL at baseline and at 1, 3, and 5 years for 1151 consecutive patients {71.7% men, median age 69 years [25th-75th percentiles (P(25)-P(75)) 59-76]} in an HF unit. Follow-up for prognosis assessment was extended to 6 years. The number of answered questionnaires was 1151 at baseline, 746 at 1 year, 268 at 3 years, and 240 at 5 years. QoL scores showed a steep decrease (indicating QoL improvement) during the first year [29 (P(25)-P(75) 16-43) at baseline vs. 15 (P(25)-P(75) 8-27) at 1 year, P < 0.001], which was tempered, yet significant up to 5 years [12 (P(25)-P(75) 7-23) at 3 years vs. 10 (P(25)-P(75) 5-21) at 5 years, P = 0.012]. We recorded 457 deaths during follow-up. In a comprehensive multivariable Cox regression analysis, baseline QoL remained a significant prognosticator during follow-up [hazard ratio (HR)(Cox) for death 1.012, 95% confidence interval 1.006-1.018, P < 0.001]. QoL monitoring showed that a score increase ≥10% between consecutive assessments stratified high-risk patients within the next 12 months (P = 0.008). CONCLUSION: Both baseline and follow-up QoL monitoring were useful for patient risk stratification in a real-life HF cohort. Worse QoL may warn of a worse prognosis. Widespread QoL monitoring in routine clinical practice is recommended.